3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neurofibromatosis 1
1
Glioma
1
Glioblastoma
1
Interventions
AZD 6244
6
mirdametinib
1
cabozantinib
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neurofibromatosis 1
×
mirdametinib
×
Clear all
NCT07521657
2026-04-13
NF118
University of Alabama at Birmingham
Phase 2
Not yet recruiting
55 enrolled